PATH EX
PATH EX is developing innovative extracorporeal blood cleansing devices aimed at diagnosing and treating sepsis by selectively removing pathogens and endotoxins from circulating blood. Their technology offers significant reductions in pathogen levels, with promising clinical implications for critical care and infectious disease management.
Industries
Nr. of Employees
small (1-50)
Products
Investigational extracorporeal blood cleansing device
An investigational blood-contacting device designed to selectively remove circulating pathogens (including multi-drug resistant bacteria) and endotoxins from patient blood to rapidly reduce bloodstream pathogen burden.
Investigational diagnostic device for pathogen capture from whole blood
An investigational device designed to selectively capture and isolate pathogens from whole blood to enable microbial identification directly from patient samples without culturing.
Investigational extracorporeal blood cleansing device
An investigational blood-contacting device designed to selectively remove circulating pathogens (including multi-drug resistant bacteria) and endotoxins from patient blood to rapidly reduce bloodstream pathogen burden.
Investigational diagnostic device for pathogen capture from whole blood
An investigational device designed to selectively capture and isolate pathogens from whole blood to enable microbial identification directly from patient samples without culturing.
Expertise Areas
- Sepsis diagnostics and therapeutics
- Extracorporeal blood treatment
- Culture-free microbial identification from whole blood
- Device performance testing and preclinical validation
Key Technologies
- Extracorporeal blood purification
- Bloodborne pathogen capture and isolation
- Endotoxin adsorption/removal
- Direct-from-blood, culture-free microbial identification